Product Information
RIZATRIPTAN 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3524 per EA under NDC 00093747243. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 31, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093747243
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA077263FDA Approved
12/31/2012
TE Code
AB
On Market Since
2/12/2013
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 10 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3524 per EA |
|---|---|
| All-time high | $1.9321 (Mar 11, 2015) |
| All-time low | $0.3131 (May 22, 2024) |
| 52-week high | $0.5115 |
| 52-week low | $0.3524 |
| Median price | $0.6895 |
| Average price | $0.8067 |
| Largest weekly change | +31.9% (Feb 18, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3524 per EA (NDC 00093747243), effective Aug 19, 2026.
How has the price of RIZATRIPTAN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG TABLET has declined 77.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG TABLET?
Since Nov 28, 2013, the NADAC for RIZATRIPTAN 10 MG TABLET has ranged from a low of $0.3131 (May 22, 2024) to a high of $1.9321 (Mar 11, 2015), with a median of $0.6895 per EA.
Are there cheaper alternatives to RIZATRIPTAN 10 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.3204 per EA — about 9% below RIZATRIPTAN 10 MG TABLET.
Who manufactures RIZATRIPTAN 10 MG TABLET?
RIZATRIPTAN 10 MG TABLET (NDC 00093747243) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.